Alibaba and AUS Merchant Services Agree to Pay $600 Million to Resolve DOJ Allegations Over Illegal Pharmaceutical Sales

Alibaba Group Holding Limited and its U.S.-based payment processor AUS Merchant Services Inc., formerly known as Alipay US, have entered a non-prosecution agreement under which they will pay $600 million to resolve Justice Department allegations that they violated the Federal Food, Drug, and Cosmetic Act, per a DOJ press release dated July 1.

The department alleges the companies failed to prevent merchants from selling and importing illegal pharmaceuticals, controlled substances, listed chemicals and pill presses into the United States through the Alibaba.com and AliExpress.com e-commerce platforms, per the release. The Wall Street Journal reported the settlement the same day.

Because the resolution takes the form of a non-prosecution agreement, the government's account remains a set of allegations rather than adjudicated findings — the companies were not indicted, and no court has ruled on the conduct described. The DOJ release and the Journal's report were the sources available; the agreement's full terms, any admissions contained in its statement of facts, and the companies' public response were not included in the material reviewed.

Background

Alibaba, founded in 1999 in Hangzhou, is China's largest e-commerce group, operating marketplaces that connect millions of third-party merchants to buyers worldwide — Alibaba.com serving business-to-business trade and AliExpress selling directly to overseas consumers. That marketplace structure sits at the heart of cases like this one: the platforms host merchant listings at a scale that makes screening for illegal goods a persistent enforcement concern for U.S. authorities.

The Federal Food, Drug, and Cosmetic Act, the 1938 statute administered by the Food and Drug Administration, governs the safety of drugs sold or imported into the United States, and pill presses and listed chemicals are separately regulated because of their role in manufacturing counterfeit tablets. Non-prosecution agreements are a standard Justice Department tool for corporate resolutions: the company pays a penalty and typically accepts compliance obligations, and the department agrees not to prosecute so long as the terms are honored.

What comes next

Non-prosecution agreements ordinarily run for a defined term during which the companies must meet compliance commitments, with prosecution revived only if they breach. Watch for publication of the agreement's full text, which would show the conduct the companies accepted responsibility for and any monitoring or platform-screening obligations attached to the $600 million resolution.